The Medicines and Healthcare products Regulatory Agency (MHRA) is adopting a more systematic approach to listening to and meaningfully involving patients and the public.
This strategy was informed by an extensive UK-wide consultation seeking the views of patients and the public on their engagement and involvement in MHRA's work. The consultation directly informed these five objectives:
- Patient and public involvement
- Internal culture
- Measuring outcomes
The MHRA wants your feedback and comments on the draft, so that they can consider whether they have missed or need to improve anything.
The consultation will be open for 5 weeks (Monday, 24 May 2021 to Monday, 28 June 2021).
Click on the link below for further information and to read the draft strategy.